Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve

Not Applicable

• Conditions: Ovarian Cancer
• Interventions: Procedure: Tubal sterilization with bipolar energy; Procedure: Bilateral Salpingectomy

• Registration Number: NCT01888159
• Lead Sponsor: Karlstad Central Hospital

Brief Summary

Randomised study to investigate if salpingectomies done to women wishing tubal sterilisation has an effect on ovarian reserve.

Detailed Description

Not available

Study Timeline

• Status Verified: 2013-06
• Study First Submitted: 2013-06-20
• Study First Submitted QC: 2013-06-25
• Last Update Submitted: 2013-06-25
• Study First Posted: 2013-06-27
• Last Update Posted: 2013-06-27
• Study Start: 2013-09
• Primary Completion: 2014-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

• Women seeking for tubal sterilisation

Exclusion Criteria

• women older than 45
• family history of ovarian cancer
• presence of menopausal symptoms
• irregular cycles
• Hormone Replacement Therapy or hormone contraceptions the last 3 months
• history of previous ovarian or uterine surgeries
• imaging suggesting an ovarian cyst or other adnexal pathology during investigation
• previous salpingectomy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Tubal Sterilization with bipolar	Tubal sterilization with bipolar energy	Salpingectomy vs Tubal Sterilisation
Bilateral Salpingectomy	Bilateral Salpingectomy	Salpingectomy vs Tubal Sterilisation

Primary Outcome Measures

Name	Time	Method
Anti-Mullerian hormone (AMH)and Follicle Stimulation Hormone (FSH)	3 months

Secondary Outcome Measures

Name	Time	Method
Anti-Mullerian hormone (AMH)	1 year
Operative time	Postoperatively
Complications	3 months

Trial Locations

Locations (1)

Department of Obstetrics and Gynecology; 🇸🇪 Karlstad, Värmaland, Sweden